Condition: Community-acquired Pneumonia, Influenza, COVID-19 · Sponsor: UMC Utrecht
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.
This description comes directly from the study's public registry record.
Cameron Green, MSc · info@remapcap.org
Svenja Peters, MSc · EU.remapcap@umcutrecht.nl
Always discuss trial participation with your own doctor first.
| University of Florida | Jacksonville, Florida, United States | Recruiting |
| Augusta University | Augusta, Georgia, United States | Not Yet Recruiting |
| University of Illinois Health | Chicago, Illinois, United States | Recruiting |
| Tulane Medical Center | New Orleans, Louisiana, United States | Not Yet Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Wake Forest Baptist Health | Winston-Salem, North Carolina, United States | Not Yet Recruiting |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
| Oregon Health and Science University | Portland, Oregon, United States | Recruiting |
| University of Pittsburgh Medical Centre | Pittsburgh, Pennsylvania, United States | Recruiting |
| Brown University - Rhode Island Hospital | Providence, Rhode Island, United States | Not Yet Recruiting |
| Canberra Hospital | Canberra, Australian Capital Territory, Australia | Recruiting |
+ 396 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02735707